ask="4.60"
ask_size="500"
average_daily_volume="212827"
bid="N/A"
bid_size="N/A"
book_value="3.29"
change="-0.10"
change_from_200_day_moving_average="-5.54"
change_from_50_day_moving_average="-1.02"
change_from_52_week_high="-13.10"
change_From_52_week_low="0.10"
change_in_percent="-2.13%"
close="4.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.54"
ebitda="-19.42M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.94"
eps_estimate_next_year="-2.56"
ex_dividend_date="N/A"
float_shares="5820000"
high="4.80"
high_52_weeks="17.70"
last_trade_date="1/31/2017"
last_trade_price="4.60"
last_trade_size="311"
last_trade_time="4:00pm"
low="4.50"
low_52_weeks="4.50"
market_capitalization="35.96M"
moving_average_200_day="10.14"
moving_average_50_day="5.62"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="4.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-54.61%"
percent_change_from_50_day_moving_average="-18.17%"
percent_change_from_52_week_high="-74.01%"
percent_change_from_52_week_low="+2.22%"
previous_close="4.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.43"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="129850"
weeks_range_52="4.50 - 17.70"
